CRB's Bill Rattray, Senior Fellow – Biopharmaceutical HVAC, explains how the program taps into CRB’s core value of entrepreneurial spirit and gives people even more opportunities to contribute to the company.
The Robert A. Winn Diversity in Clinical Trials Award Program (Winn Award Program) established by the Bristol Myers Squibb Foundation (BMSF) announced that Amgen, a global biotechnology company, has committed to contribute $8 million over the next four years.
At the World Economic Forum in Davos this week, Catalyst 2030 is launching the Catalyst Business Commitment with support from the Global Alliance for Social Entrepreneurship.
Real talk from the front lines of today’s research and manufacturing landscape
The adoption of the Kunming-Montréal Global Biodiversity Framework, signed at the UN Biodiversity Conference (COP15) last month, is without doubt a major milestone, committing the world to halting and reversing biodiversity loss by 2030.
The Beverage Industry Environmental Roundtable (BIER) recognizes that water circularity must be a part of a business’s water strategy, at the basin scale, for those actively managing water risk. As such, BIER has developed the Water Circularity Good Practices Guide.
To maximize its commitment to health equity, Medtronic is joining the Global Health Equity Network (GHEN).
Gildan Activewear Inc. (GIL: TSX and NYSE) is pleased to announce that it has been included in Corporate Knights’ 2023 Global 100 list of the world’s most sustainable corporations for the second consecutive year.
Florida’s rapidly expanding biopharma marketplace is a major contributor to advances in pioneering patient therapies and technology-focused health solutions. In order to support the state on this mission, CRB today announces the opening of its new Jacksonville office.
Liz Atlee, CBRE’s Chief Ethics & Compliance Officer, has been recognized as a 50 Most Powerful Latina (MPL) by the Association of Latino Professionals for America (ALPFA). This is the third time she has earned this prestigious honor.